Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Anal Chem ; 96(17): 6738-6745, 2024 Apr 30.
Article in English | MEDLINE | ID: mdl-38642036

ABSTRACT

The detection of low-abundance microribonucleic acid (miRNA) frequently adopted nucleic acid sequence-based amplification detection, which was found to have poor selectivity for the nonspecific amplification of template-dependent ligation in enzyme-mediated cascade reactions. Here, a highly selective detection of miRNAs was developed that combined microsphere-enhanced fluorescence (MSEF) and solid-phase base-paired hybridization. The target miRNA could be accurately and quantitatively identified through the solid-phase hybridization assay on the surface of an optical microsphere, while the detected fluorescence signal could be physically amplified by MSEF. Hereinto, the optical microsphere acted as the fluorescence amplifier and whose surface supplied the space to carry out base-paired hybridization to recognize the target miRNA via the immobilized capture DNA sequence. The detected fluorescence signal of the single-base mismatched miRNA-21 sequence was just around 12% of that of the target miRNA-21 sequence in the measurement of model miRNA-21, while the limit of detection of miRNA-21 could be 1.0 fM. The developed detection of miRNA on an optical microsphere was demonstrated to be an excellent physically amplified method to selectively and sensitively detect the target miRNA and magnificently avoid the nonspecific amplification and false-positive results, which is expected to have wide applications in pathematology, pharmacology, clinic diagnosis, and on-site screening fields as well.


Subject(s)
MicroRNAs , Microspheres , Nucleic Acid Hybridization , MicroRNAs/analysis , Fluorescence , Humans , Spectrometry, Fluorescence , Fluorescent Dyes/chemistry , Limit of Detection
2.
Zookeys ; 1193: 111-123, 2024.
Article in English | MEDLINE | ID: mdl-38481425

ABSTRACT

A taxonomic revision and redescription of the genus Eurymesosa Breuning, 1938 are presented, including a key to species. Three of the five currently accepted species are considered valid: Eurymesosaventralis (Pascoe, 1865), Eurymesosaallapsa (Pascoe, 1866) and Eurymesosaziranzhiyi Yamasako & Lin, 2016. Three junior synonyms are proposed for E.ventralis: Eurymesosaalbostictica Breuning, 1962, syn. nov., Eurymesosaaffinis Breuning, 1970, syn. nov., and Eurymesosamultinigromaculata Breuning, 1974, syn. nov. Additionally, E.allapsa (Pascoe, 1866) is resurrected from synonyms of E.ventralis. Females of E.allapsa and E.ziranzhiyi Yamasako & Lin, 2016 are described for the first time.

3.
Biosens Bioelectron ; 218: 114791, 2022 Dec 15.
Article in English | MEDLINE | ID: mdl-36242905

ABSTRACT

The far-field fluorescence amplification, the intense fluorescence emission addresses the great potential in sensitive detection to large biomolecules, was seriously ignored for the failure in amplifying the weak fluorescence excepting the electromagnetic field (EM) induced fluorescence amplification on the metallic surfaces. Here, a microsphere in hundreds of micrometers was adopted to proceed with the fluorescence amplification via building up a local dielectric surrounding for fluorophore. The wide range of contribution-angle fluorescence could be efficiently restricted within the microsphere by facilitating the energy of reflection restraining and declining the energy of refraction decaying and the intense fluorescence emission confined within the microsphere could be directly observed. The proposed microsphere amplified fluorescence was demonstrated to induce about 2600 times of improved sensitivity in the detection of the fluorescent resorufin referring that of the original resorufin solution through the laser induced fluorescence (LIF). Furthermore, the limit of detection (LOD) of human IgA was successfully obtained to 3.25 fM through the microsphere in 47.7 pL when the microsphere amplified fluorescence was utilized in the fluoroimmunoassay. We believe the microsphere amplified fluorescence would be a potential strategy to implement the sensitive fluorescence sensing.


Subject(s)
Biosensing Techniques , Humans , Fluorescence , Microspheres , Limit of Detection , Fluorescent Dyes , Immunoglobulin A
4.
Hum Vaccin Immunother ; 18(6): 2102329, 2022 Nov 30.
Article in English | MEDLINE | ID: mdl-35976684

ABSTRACT

Patients with cancer are considered at high risk of COVID-19 related complications with higher mortality rates than healthy individuals. This study investigated the perception, acceptance, and influencing factors of COVID-19 vaccination among cancer patients in Guangzhou, China. A cross-sectional survey was conducted in Guangzhou, China from August to November 2021 in two tertiary medical centers. Outpatients were recruited through hospital posters to complete a questionnaire including demographics, medical history, knowledge, and attitude toward COVID-19 vaccines and COVID-19 vaccination status. Chi-square tests and multivariable logistic regression were used to analyze predictors for acceptance of COVID-19 vaccination. In total, only 75 out of 343 patients (21.87%) had received at least one dose of COVID-19 vaccine. Twenty-one patients (6.12%) had received a recommendation about COVID-19 vaccination from their physicians. Patients who were recommended by physicians to get vaccinated (aOR = 11.71 95% CI: 2.71-50.66), with a monthly income of more than CNY 5000 (aOR = 3.94, 95% CI: 1.88-8.26) were more likely to have received COVID-19 vaccination. Cancer patients who had been diagnosed for more than one year (aOR = 0.21, 95% CI: 0.09-0.51), had received multiple cancer treatment strategies (aOR = 0.34, 95% CI: 0.16-0.74), worried about the safety of COVID-19 vaccines (aOR = 0.21, 95% CI: 0.11-0.40), were less likely to have received COVID-19 vaccination. COVID-19 vaccination uptake among cancer patients was insufficient. The proportion of cancer patients receiving vaccination recommendations from physicians remains inadequate. Physicians are expected to play an essential role in patients' knowledge of the safety and effectiveness of COVID-19 vaccines.


Subject(s)
COVID-19 , Neoplasms , Humans , COVID-19 Vaccines , Cross-Sectional Studies , COVID-19/prevention & control , Vaccination , China/epidemiology , Neoplasms/complications , Neoplasms/therapy , Perception
5.
J Colloid Interface Sci ; 545: 25-34, 2019 Jun 01.
Article in English | MEDLINE | ID: mdl-30861479

ABSTRACT

In this study, we propose a novel template and chemical activation method to fabricate the nitrogen and fluorine co-doped hierarchically porous carbon with polytetrafluoroethylene-polyaniline as the precursor and KOH as the activation reagent. The key to this strategy is the utilization of polytetrafluoroethylene as an additive during the process, which not only serves as a fluorine source but also acts as a template to increase the specific surface area. Moreover, polytetrafluoroethylene disappears after carbonization without requiring a complicated template-removal process. The as-prepared materials possess a favorable hierarchical porous structure that is conductive to the transportation and diffusion of ions. They also acquire effective nitrogen and fluorine co-doping to further improve the electrochemical performance. The optimized carbon material displays a high specific capacitance (291 F g-1 at 0.5 A g-1) and maintains 180 F g-1 even at 100 A g-1 in 6 M KOH. Moreover, it presents an excellent cycling performance with 95.5% capacitance retention after 10,000 cycles. The fabricated symmetric supercapacitor delivers high energy densities of 12.91 Wh kg-1. These results represent a new performance record for nitrogen and fluorine co-doped porous carbon-based supercapacitors, rendering the polytetrafluoroethylene particles to be a promising template for producing porous carbon materials.

SELECTION OF CITATIONS
SEARCH DETAIL
...